Stage IIIA Intraocular Melanoma Completed Phase 2 Trials for GP-100 antigen (DB14800)

IndicationStatusPhase
DBCOND0030838 (Stage IIIA Intraocular Melanoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00085189Vaccine Therapy in Treating Patients With Stage IIC-IV MelanomaTreatment